Jeong Gicheol
Science and Technology Policy Institute (STEPI), Sicheong-daero, Sejong-si, Republic of Korea.
Public Health Genomics. 2017;20(3):166-173. doi: 10.1159/000479290. Epub 2017 Aug 18.
In June 2016, Korea permitted direct-to-consumer genetic testing (DTC-GT) on 42 genes. However, both the market and industry have not yet been fully activated. Considering the aforementioned context, this study provides important insights.
The Korean DTC-GT policy assessment is based on consumer preference analysis using a discrete choice experiment. In August 2016, a web-based survey was conducted to collect data from 1,200 respondents.
The estimation results show that consumers prefer a DTC-GT product that is cheap, tests various items or genes, offers accurate test results, and guarantees the confidentiality of all information. However, consumers are not entirely satisfied by current DTC-GT products due to the existence of insufficient and/or inadequate policies. First, the permitted testing of 42 genes is insufficient to satisfy consumers' curiosity regarding their genes. Second, the accuracy of the DTC-GT products has not been fully verified, assessed, and communicated to consumers. Finally, regulatory loopholes that allow information leaks in the DTC-GT process can occur.
These findings imply that DTC-GT requires an improvement in government policy-making criteria and the implementation of practical measures to guarantee test accuracy and genetic information.
2016年6月,韩国允许对42个基因进行直接面向消费者的基因检测(DTC-GT)。然而,市场和行业尚未完全激活。考虑到上述背景,本研究提供了重要见解。
韩国DTC-GT政策评估基于使用离散选择实验的消费者偏好分析。2016年8月,进行了一项基于网络的调查,以收集来自1200名受访者的数据。
估计结果表明,消费者更喜欢价格便宜、检测各种项目或基因、提供准确检测结果并保证所有信息保密的DTC-GT产品。然而,由于存在不足和/或不完善的政策,消费者对当前的DTC-GT产品并不完全满意。首先,对42个基因的许可检测不足以满足消费者对自身基因的好奇心。其次,DTC-GT产品的准确性尚未得到充分验证、评估并传达给消费者。最后,在DTC-GT过程中可能会出现允许信息泄露的监管漏洞。
这些发现意味着DTC-GT需要改进政府决策标准并实施实际措施以保证检测准确性和基因信息。